Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04954261
Other study ID # NI18018J
Secondary ID 2018-A00763-52
Status Withdrawn
Phase
First received
Last updated
Start date December 6, 2018
Est. completion date December 6, 2018

Study information

Verified date December 2021
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to introduce delirium detection and try to determine the prevalence of delirium in Pediatric Intensive Care Unit (PICU) using a validated tool : the Cornell Assessment of Pediatric Delirium (CAPD) for every patient twice a day.


Description:

Delirium is a frequent affection in ICU. In adult population, its prevalence is 20-50% in non intubated patients and 60-80% in patients under invasive ventilation. It is also frequent in paediatric population, but less diagnosed, whereas it can lead to higher duration stay, higher morbidity, traumatic injuries, acute stress, memory losses and post-traumatic stress syndrome. Since 2016, international guidelines recommend to look for delirium in paediatric population in PICU. There are 3 recommended tools to diagnose this affection: psCAM-ICU (6 months-5 years old), pCAM-ICU (5 years old-18 years old) and CAPD (birth-18 years old). None of these validated tools have been translated in French. The principal objective is to study the practicability of twice a day detection of delirium in PICU using the CAPD. Investigators will first used a validation process to translate the CAPD in French, based on the validation method for psychological questionnaires suggested by Vallerand. Then they will ask the paramedics to evaluate through the CAPD every consecutive patient/12 hours, every day during their stay in PICU, except for those completely unresponsive or under curare. This systematic evaluation will take place for 2 consecutive months. For every patient, data will be collected about their age, sexe, term of birth, mental affection status, diagnosis at entry, and daily risk of mortality score, length of stay, ventilation, pain evaluation and treatment, withdrawal evaluation, surroundings, use of hypnotic treatment, steroids, opioids and ketamine. The secondary aims are to determine the prevalence of delirium with the data collected, to ask whether or not the French version of CAPD has been easily and correctly used, can help to diagnose delirium, and whether investigators can find some associated parameters to delirium.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 6, 2018
Est. primary completion date December 6, 2018
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - Being hospitalized in PICU during the inclusion period - Age 0 to 18 years old Exclusion Criteria: - Patient with a state of sedation that does not allow the assessment of a change in the state of consciousness or cognitive functioning (equivalent score Richmond Agitation-Sedation Scale RASS <-3 or COMFORT B <11) - Patient or Parental opposition to the observational study

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
CAPD
CAPD evaluation every day per 12hours during their stay in PICU

Locations

Country Name City State
France Necker Enfants Malades Hospital Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of delirium in the PICU population Number of CAPD evaluated > 9 / total number of CAPD evaluated 2 months
Secondary Applicability of the CAPD by the paramedics 5 questions :
Whether or not they have already heard about delirium
Whether or not they know the symptoms of delirium in children and adolescents
Whether or not they have already been confronted to a state of delirium in the Pediatric Intensive Care Unit
Whether of not they think it would be useful to have a specific scale to diagnose delirium in the Pediatric Intensive Care Unit
Whether or not they think it would be feasible to use such a scale regularly in the Pediatric Intensive Care Unit The proposed answers will be Yes, No or I don't know for each question The analysis will be qualitative and quantitative.
Before inclusion period
Secondary Applicability of the CAPD by the paramedics after the 2 months period The same 5 questions of the pre-test, 5 new closed-ended questions and 3 open-ended questions :
Whether or not they had difficulties evaluating patients with the CAPD
How they evaluate the duration of the evaluation by the CAPD
Whether or not they evaluated the patients with a colleague
Whether or not they think that the assessment of delirium by the CAPD is relevant among PICU patients
Whether or not they think that a long-term evaluation of delirium by the CAPD is feasible in this PICU unit
1- If difficulties of evaluating patients with the CAPD : quote the difficulties 2- In which categories of patients do they think that the CAPD in not adapted 3- Comment or suggestions to improve the use of the scale
2 months
Secondary Use of the CAPD by the paramedics % of CAPD completed during the 2 months period 2 months
Secondary Age Potential associated factors to delirium 2 months
Secondary Sex Potential associated factors to delirium 2 months
Secondary Term of birth Potential associated factors to delirium 2 months
Secondary Prior neurological impairment Potential associated factors to delirium 2 months
Secondary Diagnosis (motivating hospitalization in intensive care) Potential associated factors to delirium 2 months
Secondary Severity score on arrival (PIM 3) Potential associated factors to delirium. Pediatric Index of Mortality (PIM) 3 is a published and open acces program whith 10 variables about the patients (7 binary variables and 3 quantitative ones), that predicts the death probability of the patient. One evaluation per patient at the admission in the PICU unit. 2 months
Secondary Daily severity score (PELOD 2) Potential associated factors to delirium. PELOD 2 (PEdiatric Logistic Organ Dysfunction) is a published and open acces program that includes ten variables corresponding to five organ dysfunctions. It predicts a daily percentage of mortality. One evaluation per day per patient during the PICU unit stay. 2 months
Secondary Duration of hospitalization Potential associated factors to delirium 2 months
Secondary Death or survival of the patient Potential associated factors to delirium 2 months
Secondary Mechanical ventilation, non invasive ventilation or spontaneous ventilation Potential associated factors to delirium 2 months
Secondary Mechanical ventilation time Potential associated factors to delirium 2 months
Secondary Presence of parents Potential associated factors to delirium 2 months
Secondary Presence of pain Potential associated factors to delirium.
Pain was evaluated through the appropriate scale amongst :
Comfort B (pediatric behavioural scale, ventilated, sedated and/or comatose patient): seven items scored 1 to 5, a total score greater than or equal to 17/35 indicating a state of pain,
or EVENDOL (behavioural scale for conscious patients between birth and 6 years old): five items scored 0 to 3, a total score greater than or equal to 3/15 indicating a state of pain,
or FLACC (Face Leg Activity Cry Consolability) (pediatric behavioural scale, usable in patients with cognitive impairment): five items scored 0 to 2, a total score greater than or equal to 3/10 indicating a state of pain,
Patients able to assess pain felt :
Numerical Scale (for patients over 10 years old) a score greater than or equal to 3/10 indicating a state of pain,
or Visual Analogue Scale (for patients between 6 and 10 years old), a score greater than or equal to 3/10 indicating a state of pain.
2 months
Secondary withdrawal or not Potential associated factors to delirium. Withdrawal was evaluated through the scale WAT-1 (Wthdrawal Assessing tool version 1): ten items scored 0 or 1, and 1 item scored 0 to 2, a total score greater than or equal to 3/12 indicating a state of withdrawal. 2 months
Secondary Use of benzodiazepines, ketamine, corticosteroids or opioids Potential associated factors to delirium 2 months
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A